Proveca Ltd is a UK-based pharmaceutical company which specialises in the development and licensing of medicines to address unmet medical needs in children.
Currently, over half of the medicines taken by children are not in an age-appropriate format and/or are not licensed for paediatric use.
Proveca are leaders in licensing children’s medicines using the European regulatory framework, the Paediatric Use Marketing Authorisation (PUMA) process. The regulation was specifically designed to increase the number of off-patent medicines being developed and licensed for children.
Proveca collaborated with the European Medicine Agency’s Paediatric Committee to gain a PUMA in September 2016 for the treatment of sialorrhoea in children.
The dynamic and experienced team at Proveca are seeking to improve the lives of children, many of whom require long-term drug treatment for chronic conditions.
Working with clinicians, parents, carers and children, Proveca are leading the way to provide licensed children’s medicines that are tailored to children’s specific requirements.
We provide information and educational materials for healthcare professionals, parents and carers. Please click on the above links.
If you need any further assistance, please check the contacts page for details on how to contact us. If you wish to report a side-effect or concern about our products, please go to the report a problem page.
PCOM-LP-V2Reviewed November 2021READ MORE
Learn more about medicines for children.
Information for investors or media relations.